Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2020-04-30 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200430 UCB AGM 2020 ENG final.pdf
AGM Information Classification · 99% confidence The document explicitly details the proceedings and outcomes of the 'UCB's General Meeting of Shareholders (AGM) and Extraordinary General Meeting (EGM)'. Key elements include the approval of the 2019 gross dividend (€ 1.24 per share), the re-appointment of directors, and the approval of all agenda items. This content directly corresponds to the purpose of an Annual General Meeting (AGM) presentation or report summary. Although it mentions the Integrated Annual Report 2019 is available elsewhere, the primary focus of this text is summarizing the meeting itself. Therefore, the most appropriate classification is AGM-R.
2020-04-30 English
200430 UCB AGM 2020 FR Final.pdf
AGM Information Classification · 99% confidence The document is titled 'Assemblée générale des actionnaires d'UCB' (UCB Shareholders' General Meeting) and explicitly states that the Ordinary General Meeting (AGO) and Extraordinary General Meeting (AGE) were held on April 30, 2020. It details key outcomes, such as the approval of the 2019 dividend (€1.24 per share) and the re-election of directors. This content directly relates to the proceedings and outcomes of a shareholder meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). It is not a general regulatory filing (RNS) because it is highly specific to the AGM, nor is it a proxy statement (PSI) as it reports the results, not solicits votes.
2020-04-30 French
200430 UCB AGM 2020 NDL Final.pdf
AGM Information Classification · 100% confidence The document text is titled 'Algemene vergadering van aandeelhouders UCB' (General Meeting of Shareholders UCB) and explicitly discusses the outcomes of the 'gewone algemene vergadering van aandeelhouders (AV) en zijn buitengewone algemene vergadering van aandeelhouders (BAV)' (Ordinary General Meeting of Shareholders (AGM) and its Extraordinary General Meeting of Shareholders (EGM)). Key elements mentioned include the approval of the gross dividend (€ 1.24 per share), the reappointment of directors, and the fact that all agenda items were approved by shareholders. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information).
2020-04-30 Dutch
200430 Minutes EGM.pdf
AGM Information Classification · 98% confidence The document text details the proceedings of an 'extraordinary general meeting of the shareholders' of UCB, dated April 30, 2020. The primary agenda item (Resolution 1) is the 'ADAPTATION TO THE COMPANIES 'AND ASSOCIATIONS CODE AMENDMENT OF THE ARTICLES OF ASSOCIATION RENEWAL OF THE AUTHORIZED CAPITAL AUTHORIZATION TO ACQUIRE OWN SHARES'. The text explicitly discusses amending the Articles of Association to align with the new Belgian Code of Companies and Associations (BCCA), including specific changes to articles regarding capital, board structure, and shareholder meetings. This content—minutes or resolutions from a general meeting concerning corporate governance and statutory changes—is characteristic of an Annual General Meeting (AGM) or an Extraordinary General Meeting (EGM) documentation. Since the document is the record of the meeting itself, and it covers fundamental corporate governance and statutory changes, it aligns best with the 'AGM Information' category, even though it is an extraordinary meeting, as it deals with the formal business conducted at such a gathering.
2020-04-30 English
200430 Minutes AGE Extrait.pdf
AGM Information Classification · 99% confidence The document is a notarial deed detailing an Extraordinary General Meeting (Assemblée Générale Extraordinaire) of the company UCB, held on April 30, 2020. The primary purpose of this meeting, as detailed under 'Ordre du jour' (Agenda), is the 'ADAPTATION AU CODE DES SOCIETES ET DES ASSOCIATIONS' (Adaptation to the Code of Companies and Associations) and related resolutions like authorizing the acquisition of own shares. This document records the decisions made during a shareholder meeting regarding statutory changes and corporate governance alignment with new Belgian law (CSA). While it involves shareholder voting, the core content is the formal record of decisions made at a general meeting, which often accompanies or follows the formal voting results announcement. However, the text explicitly details the proceedings, resolutions, and the composition of the meeting, which strongly aligns with the documentation surrounding an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the resolutions concern fundamental corporate structure and compliance, and the document is the official record of the meeting itself (not just a voting result announcement), 'AGM-R' (AGM Information/Materials) is the most appropriate classification, as it covers the materials presented and decided upon during such a meeting.
2020-04-30 French
200430 Notulen BAV extract.pdf
AGM Information Classification · 98% confidence The document text is a notarial deed detailing the proceedings of an 'buitengewone algemene vergadering der aandeelhouders' (Extraordinary General Meeting of Shareholders) for UCB NV, dated April 30, 2020. The primary agenda item is the 'AANPASSING AAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN' (Adaptation to the Code of Companies and Associations), involving numerous statutory amendments. Since this document records the decisions and minutes of a shareholder meeting, it directly relates to the governance and formal proceedings of the company's general assembly. While it is a formal legal record, the content is centered around the meeting itself and the resolutions passed, which aligns best with the scope of an Annual General Meeting (AGM) or a related formal meeting record, even though it is an Extraordinary General Meeting (EGM) focused on statutory changes. Given the options, 'AGM-R' (AGM Information) is the closest fit for formal meeting documentation, especially since the text details the bureau, attendance, and agenda items of the meeting itself, rather than just a proxy statement (PSI) or a general regulatory filing (RNS). The document is substantial and contains the substance of the meeting, not just an announcement of it.
2020-04-30 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.